Validity and reliability of self-reported health indicators among women attending organized mammographic screening.

CONCLUSIONS: Norwegian women attending the screening program are reasonably accurate in self-reporting their breast cancer and mammography histories. On average, women consistently reported weight and height within one kg/cm. PMID: 29366395 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Public Health - Category: International Medicine & Public Health Authors: Tags: Scand J Public Health Source Type: research

Related Links:

CONCLUSION: By using a diverse dataset and comparing the diagnostic accuracy of three imaging modalities commonly used in breast cancer detection and diagnosis, this study also demonstrated that mammography, ultrasonography and MRI had different diagnostic performance in breast tumor identification. Among them, MRI yielded the highest performance even though the unexpected specificity may lead to over-diagnosis, and ultrosonography is slightly better than mammography. PMID: 30103371 [PubMed - as supplied by publisher]
Source: Journal of X-Ray Science and Technology - Category: Radiology Tags: J Xray Sci Technol Source Type: research
(University of California - San Francisco) Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco. Some patients go without the annual mammograms that experts recommend, while others with the same cancer diagnosis receive full-body scans that expose them to significant amounts of radiation and are not recommended by experts.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
ConclusionA SNB should become the standard after NACT if case of a cN0. If after NACT the PET CT has normalized, no ALND should be performed if the SN is negative.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Though mammography helps to provide early detection of breast cancer, it is a modality that suffers from limitations, particularly in dense breasts. A new technology, developed at Caltech, may have the potential to eclipse mammographies for spotting ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Diagnostics Ob/Gyn Radiology Surgery Source Type: blogs
This study was to assess a gastrin-releasing peptide receptor (GRPR) and integrin αvβ3 dual targeting tracer 68Ga-BBN-RGD for positron emission tomography (PET)/computed tomography (CT) imaging of breast cancer and metastasis. Materials and Methods: Twenty-two female patients were recruited either with suspected breast cancer on screening mammography (n = 16) or underwent breast cancer radical mastectomy (n = 6). All the 22 patients underwent PET/CT at 30-45 min after intravenous injection of 68Ga-BBN-RGD. Eleven out of 22 patients also accepted 68Ga-BBN PET/CT within 2 weeks for comparison. A final diagnosis wa...
Source: Theranostics - Category: Molecular Biology Authors: Tags: Research Paper Source Type: research
Researchers have developed a quicker, better and cheaper way than mammograms to detect breast cancer: a laser scanner that can find tumors in 15 seconds.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
(California Institute of Technology) Lihong Wang, Caltech's Bren Professor of Medical Engineering and Electrical Engineering, has developed a laser-sonic scanning system that can identify breast tumors quickly and safely.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
This study was designed to assess a novel gastrin releasing peptide receptor (GRPR) and integrin αvβ3 dual targeting PET/CT using 68Ga-BBN-RGD in patients with breast cancer and metastasis, and to evaluate the correlation between imaging quantification and immunohistochemical result of GRPR and integrin αvβ3 expression within primary and metastatic breast cancer lesions. Methods: A macrocyclic chelator, 1,4,7-triazacyclononane-N,N’,N"-triacetic acid (NOTA) conjugated BBN-RGD was synthesized and labeled with 68Ga. With ethics committee approval and written informed consent, 22 patients (F, a...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: First-in-Human & amp; New Human Applications Source Type: research
Conclusions: WB PET SUV's and PEM SUV's were highly correlated, and both were correlated to Ki-67 and histological grade. Additional lesions were detected in PEM scans in a significant number of patients compared to WB PET, while another significant proportion of patients had lesions not visualized only in PEM due to positioning.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Breast Cancer: Detection and Staging Source Type: research
Conclusions: This pilot study indicated that the uptake of gastrin-releasing peptide receptor antagonist 68Ga-NOTA-RM26 may correlate with ER expression in breast cancer. To avoid the physiological uptake of 68Ga-NOTA-RM26 in normal breast tissue, it is suggested that this examination not be performed during the secretory phase of the menstrual cycle. Figure legend: Figure 1. A 60-year-old patient with breast invasive ductal carcinoma showed intense 68Ga-RM26 uptake in the primary tumor (blue arrows) and lymph node metastasis (yellow arrows) on the left side. The tumor stained positively for ER (F) and GRPR (G); the lymph ...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Breast Cancer: Novel Tracers, Response Biomarkers, and Therapy Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Epidemiology | International Medicine & Public Health | Mammography | Norway Health | PET Scan | Statistics | Study | Women